摘要:
For digital demodulation of a quadrature amplitude- or phase-modulated signal (xE(t)), this is sampled with a sampling frequency fs and A/D converted, which has the relationship f s = 4 · f 0 1 + 2 · λ with the carrier frequency f0, whereby &lgr; is a whole number greater than or equal to zero. The multiplications of the sampled and A/D converted quadrature amplitude- or phase-modulated signal usually necessary for demodulation, with the signal cos ( 2 · π · f 0 f s · k ) and the signal sin ( 2 · π · f 0 f s · k ) can be easily performed, whereby the individual sample values of the quadrature amplitude- or phase-modulated signal are multiplied by the value −1, 0 or 1.
摘要:
The sculpture or bendy blanket has a resilient bendable grid frame assembly which allows the sculpture blanket to have all the properties of any blanket and a new aspect of the ability to independently hold usual and unusual forms and shapes. The sculpture blanket is bendable, resilient, able to be sculpted and molded, is formable, adjustable, and able to be articulated into a multitude number of abstract and unusual nonstandard forms for fabric material, and hold its shape until manipulated into a new form by the user; while at the same time provides coziness, warmth, entertainment and protection against environmental elements. The sculpture blanket is resilient, and therefore, constructed using a material that has a property that will allow it to be bent and reformed repeatedly, without damaging the frame, of the frame losing its properties over time to bend or hold the desired shape.
摘要:
The invention relates to alkynylpyrimidines according to the general formula (I): in which A, R1, R2, R3, R4, R5, and R6 are as defined in the claims, and salts, N-oxides, metabolites, solvates, tautomers and prodrugs thereof, to pharmaceutical compositions comprising said alkynylpyrimidines, to methods of preparing said alkynylpyrimidines, as well as to uses thereof for manufacturing a pharmaceutical composition for the treatment of diseases of dysregulated vascular growth or of diseases which are accompanied with dysregulated vascular growth, wherein the compounds effectively interfere with Tie2 and VEGFR2 signalling.
摘要:
The invention relates to substituted sulphoximines according to the general formula (I): in which A, E, G, X, R1, R2, R3, R4, R5, R6, R7, R8, m, p, q, are given in the claims, and salts thereof, to pharmaceutical compositions comprising said substituted sulphoximines, to methods of preparing said substituted sulphoximines as well as the use thereof for manufacturing a pharmaceutical composition for the treatment of diseases of dysregulated vascular growth or of diseases which are accompanied with dysregulated vascular growth, wherein the compounds effectively interfere with Tie2 signalling.
摘要:
The invention relates to novel nicotinamide pyridinureas as VEGF receptor kinase inhibitors, their production and use as pharmaceutical agents for preventing or treating diseases that are triggered by persistent angiogenesis.
摘要:
The invention relates to novel anthranilamide pyridinureas as VEGF receptor kinase inhibitors, their production and use as pharmaceutical agents for preventing or treating diseases that are triggered by persistent angiogenesis.
摘要:
A method for exchanging information between a first device and a second device connected via a communication link, the communication link supporting a query command and at least a further command, where each command includes a specific command code is described. The method comprises transmitting a query command code and data from the first device via the communication link, the data identifying a specific command, receiving the query command code and the data at the second device, transmitting reply data from the second device via the communication link, the reply data including at least a first segment and a second segment, and receiving the reply data at the first device, wherein the first segment includes information whether the specific command is supported, wherein, if the specific command is not supported, the second segment includes information identifying an alternative command to the specific command.
摘要:
The invention relates to alkynylpyrimidines according to the general formula (I): in which A, R1, R2, R3, R4, R5, and R6 are as defined in the claims, and salts, N-oxides, metabolites, solvates, tautomers and prodrugs thereof, to pharmaceutical compositions comprising said alkynylpyrimidines, to methods of preparing said alkynylpyrimidines, as well as to uses thereof for manufacturing a pharmaceutical composition for the treatment of diseases of dysregulated vascular growth or of diseases which are accompanied with dysregulated vascular growth, wherein the compounds effectively interfere with Tie2 and VEGFR2 signalling.
摘要:
Novel VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones and their use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are selected.
摘要:
The invention relates to novel nicotinamide pyridinureas as VEGF receptor kinase inhibitors, their production and use as pharmaceutical agents for preventing or treating diseases that are triggered by persistent angiogenesis.